Related references
Note: Only part of the references are listed.Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi
K. M. Little et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi
D. Thindwa et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings
I Pathmanathan et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program Data
Suzue Saito et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Impact of test and treat recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries
Menard Laurent Chihana et al.
PLOS ONE (2018)
High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland
L. V. Adams et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya
Sylvia M. LaCourse et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland A prospective observational feasibility study
Yolanda Mueller et al.
MEDICINE (2017)
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Anani Badje et al.
LANCET GLOBAL HEALTH (2017)
Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study
Florence Nafula Okwara et al.
BMC INFECTIOUS DISEASES (2017)
Routine implementation of isoniazid preventive therapy in HIV-infected patients in seven pilot sites in Zimbabwe
K. C. Takarinda et al.
PUBLIC HEALTH ACTION (2017)
Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study
Mahlet Semu et al.
BMC INFECTIOUS DISEASES (2017)
Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy
Anthony D. Harries et al.
BMC PUBLIC HEALTH (2016)
Scaling-up antiretroviral therapy in Malawi
Andreas Jahn et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis
Hannah Alsdurf et al.
LANCET INFECTIOUS DISEASES (2016)
Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point
Yared Tadesse et al.
PLOS ONE (2016)
Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis
H. Kanyerere et al.
PUBLIC HEALTH ACTION (2016)
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis
Rishi K. Gupta et al.
AIDS (2015)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
Christine Danel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials
Henok Tadesse Ayele et al.
PLOS ONE (2015)
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
Molebogeng X. Rangaka et al.
LANCET (2014)
Routine programmatic delivery of isoniazid preventive therapy to children in Cape Town, South Africa
M. Osman et al.
PUBLIC HEALTH ACTION (2013)
How operational research influenced the scale up of antiretroviral therapy in Malawi
Anthony D. Harries et al.
HEALTH CARE MANAGEMENT SCIENCE (2012)
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
Taraz Samandari et al.
LANCET (2011)
Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review
Jennifer Uyei et al.
LANCET INFECTIOUS DISEASES (2011)
Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006
Barudi Mosimaneotsile et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV
Kevin P. Cain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Using Touchscreen Electronic Medical Record Systems to Support and Monitor National Scale-Up of Antiretroviral Therapy in Malawi
Gerald P. Douglas et al.
PLOS MEDICINE (2010)
Share Paper
